Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) are emerging agents used for the treatment of various malignant tumors. As ICIs are generally used for unresectable malignant tumors, there have been only a few reports of patients who underwent surgery after receiving these drugs. Therefore, it remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Kimimasa, Kobayashi, Shin, Kudo, Masashi, Sugimoto, Motokazu, Takahashi, Shinichiro, Nakamura, Yoshiaki, Kawazoe, Akihito, Shitara, Kohei, Kinoshita, Takahiro, Gotohda, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688679/
https://www.ncbi.nlm.nih.gov/pubmed/34928436
http://dx.doi.org/10.1186/s40792-021-01346-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688679/
https://www.ncbi.nlm.nih.gov/pubmed/34928436
http://dx.doi.org/10.1186/s40792-021-01346-w

Ejemplares similares